Disease and conditions Related News
Zentek: Developing nanotechnology for advancements in HVAC, healthcare and more
Zentek’s nanotechnology offers novel and sustainable solutions for some of the most challenging issues in HVAC, healthcare and beyond.
Graphene is a carbon-based nanomaterial with...
Preserving blood and its components to alleviate bleeding disorders
B Medical Systems discusses how the company’s Blood Management Solutions can expertly preserve blood to help those affected by bleeding disorders.
Bleeding disorders are a...
Health Europa Quarterly Issue 25
Welcome to Health Europa Quarterly Issue 25, where you will discover the latest health research addressing global health policy, antimicrobial resistance, medical technology, disease management,...
Health Europa Quarterly Issue 22
Welcome to Health Europa Quarterly Issue 22, which features fascinating expert insights in the fields of public health, Alzheimer's disease, antimicrobial resistance, women’s health, nutrition,...
Low-intensity Vibration Therapy: Combatting an osteoporosis epidemic
MyBones outlines the challenges to global bone health revealed by SCOPE 2021, and how Low-intensity Vibration therapy offers an innovative way to prevent and...
Mitigating contamination threats with microbial analysis and water testing
Nova Biologicals, a leading microbiological testing service, outlines how microscopic contaminants can be mitigated and contained through microbial analysis methods such as water testing.
Microscopic...
Transforming diagnostic testing for biomarkers with Egoo.health platform
Egoo.Health Platform is transforming testing for biomarkers with their diagnostics device, which delivers everyone from ordinary people to healthcare professionals, the opportunity to monitor...
Big Boost for NervGen’s Phase II Clinical Trials
In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...
Amarin: Changing the landscape of residual cardiovascular disease risk
World-leading pioneers of the pharmaceutical industry, Amarin Corporation, comprehensively explore the ever-evolving landscape of cardiovascular disease, analysing the current challenges facing mitigating the impacts...
An innovative device for multi-organ failure support
The ADVOS integrated 4-in-1 multi-organ support solution could dramatically improve survival rates of critically ill organ failure patients, including those with COVID-19.
Multi-organ failure (MOF)...
MonitAir: Empowering patients to monitor their symptoms of COPD
MonitAir is a cutting-edge eHealth product that enables patients to monitor their symptoms of COPD accurately, providing them with unprecedented insights into their condition...
Understanding the impact of long COVID to improve future treatment
A study into long COVID has highlighted the need for greater research, diagnostic procedures, and pandemic preparedness moving forward.
For the foreseeable future, the coronavirus...
Research highlights lack of support for taste and smell loss patients
People who have lost their sense of smell are not getting the support they need from the healthcare system, new research has suggested.
A study...
Revolutionising the study of the cellular origins of disease
A breakthrough in microscopy and endoscopy is set to revolutionise how we study the cellular origin of diseases – advancing the field of precision...
Advancing understanding of TB and respiratory infections with lung-on-chip
An innovative ‘lung-on-chip’ is providing new insights into the body’s response to early tuberculosis infection and could provide a model for future research into...
Cystic fibrosis: searching for a cure
The Cystic Fibrosis Foundation aims to deliver treatment, care and – eventually – a cure for CF.
Cystic fibrosis (CF), which affects more than 70,000...
Molecular cause explains a genetic form of microcephaly
Scientists have helped to explain a genetic form of microcephaly by uncovering a molecular cause for the rare disease.
Microcephaly is a condition where babies'...
Bridging the gap in heart failure awareness
While heart failure affects 64 million people worldwide, a new Global survey shows that heart failure is a ‘blind spot’ for the public and...
Experimental cancer drug is potential treatment for rare Rett syndrome
Scientists have investigated the use of an experimental cancer drug for the treatment of the rare Rett syndrome, finding that it extended life in...
Better control of blood sugar for diabetics with two-in-one injection
An experimental two-in-one insulin injection has been created to help diabetics gain better control of their blood sugar.
The injection, developed by researchers at Stanford...
